Cargando…
Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Patients Undergoing Surgical Resection
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal and aggressive cancers with a less than 6% five-year survival rate. Circulating microRNAs (miRNAs) are emerging as a useful tool for non-invasive diagnosis and prognosis estimation in the various cancer types, including PDAC. Our stud...
Autores principales: | Gablo, Natalia, Trachtova, Karolina, Prochazka, Vladimir, Hlavsa, Jan, Grolich, Tomas, Kiss, Igor, Srovnal, Josef, Rehulkova, Alona, Lovecek, Martin, Skalicky, Pavel, Berindan-Neagoe, Ioana, Kala, Zdenek, Slaby, Ondrej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464450/ https://www.ncbi.nlm.nih.gov/pubmed/32751582 http://dx.doi.org/10.3390/jcm9082440 |
Ejemplares similares
-
Cell-free microRNAs as Non-invasive Diagnostic and Prognostic Bio- markers in Pancreatic Cancer
por: Gablo, Natalia A., et al.
Publicado: (2019) -
MiR-215-5p Reduces Liver Metastasis in an Experimental Model of Colorectal Cancer through Regulation of ECM-Receptor Interactions and Focal Adhesion
por: Machackova, Tana, et al.
Publicado: (2020) -
MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma
por: Vychytilova-Faltejskova, Petra, et al.
Publicado: (2015) -
MicroRNA Biogenesis Pathway Genes Are Deregulated in Colorectal Cancer
por: Vychytilova-Faltejskova, Petra, et al.
Publicado: (2019) -
Morphine Analgesia, Cannabinoid Receptor 2, and Opioid Growth Factor Receptor Cancer Tissue Expression Improve Survival after Pancreatic Cancer Surgery
por: Vecera, Lubomir, et al.
Publicado: (2023)